Cargando…
Ovarian adrenal rest tumor in congenital adrenal hyperplasia: Is medical treatment the first line option?
Ovarian adrenal rest tumors (OARTs) are very rare. We describe a case of a young woman with uncontrolled classical congenital adrenal hyperplasia (CCAH), presenting with bilateral OARTs, successfully treated with steroid replacement. A 20-year-old woman, known to have 21OH-CCAH, presented with sever...
Autores principales: | , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Sociedade Brasileira de Endocrinologia e Metabologia
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10065401/ https://www.ncbi.nlm.nih.gov/pubmed/34762785 http://dx.doi.org/10.20945/2359-3997000000415 |
_version_ | 1785018101265334272 |
---|---|
author | Koren, Ronit Koren, Shlomit Khashper, Alla Benbassat, Carlos Pekar-Zlotin, Marina Vaknin, Zvi |
author_facet | Koren, Ronit Koren, Shlomit Khashper, Alla Benbassat, Carlos Pekar-Zlotin, Marina Vaknin, Zvi |
author_sort | Koren, Ronit |
collection | PubMed |
description | Ovarian adrenal rest tumors (OARTs) are very rare. We describe a case of a young woman with uncontrolled classical congenital adrenal hyperplasia (CCAH), presenting with bilateral OARTs, successfully treated with steroid replacement. A 20-year-old woman, known to have 21OH-CCAH, presented with severe abdominal pain, vomiting, diarrhea, and fever. As a result of poor compliance, 6 months before her admission hirsutism worsened and amenorrhea, hyperpigmentation, and weakness developed. ACTH levels were 278 < pmol/L and 17OHP 91.3 nmol/L. She was admitted for parenteral antibiotics and high-dose hydrocortisone treatment. CT revealed bilateral juxta-ovarian masses (6.2 x 3.6 x 7.4 cm left and 5 x 2.2 x 3.2 cm right) that on MRI were iso-intense in T1 and hypointense in T2, with early enhancement and rapid washout. One week of high-dose hydrocortisone resulted in significant clinical and laboratory improvement and the patient was discharged with 2 mg dexamethasone/day. One month later US revealed shrinkage of the masses and dexamethasone dose was decreased. At three months from discharge, she has resumed regular menses, and a repeated MRI revealed the para-ovarian masses have shrunk. One year after the diagnosis, the para-ovarian masses have shrunk more to 2.8 x 1.9 x 4.3 on the left and 2.1 x 0.9 x 1.2 on the right with less contrast enhancement in comparison to previous test possibly due to fibrotic changes of the tissue. OARTs are rare tumors with a poorly known natural history, and surgery has been the first option in the few reported cases. We demonstrate that medical treatment is a good alternative, leading to significant tumor shrinkage over a short period. |
format | Online Article Text |
id | pubmed-10065401 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2021 |
publisher | Sociedade Brasileira de Endocrinologia e Metabologia |
record_format | MEDLINE/PubMed |
spelling | pubmed-100654012023-04-01 Ovarian adrenal rest tumor in congenital adrenal hyperplasia: Is medical treatment the first line option? Koren, Ronit Koren, Shlomit Khashper, Alla Benbassat, Carlos Pekar-Zlotin, Marina Vaknin, Zvi Arch Endocrinol Metab Case Report Ovarian adrenal rest tumors (OARTs) are very rare. We describe a case of a young woman with uncontrolled classical congenital adrenal hyperplasia (CCAH), presenting with bilateral OARTs, successfully treated with steroid replacement. A 20-year-old woman, known to have 21OH-CCAH, presented with severe abdominal pain, vomiting, diarrhea, and fever. As a result of poor compliance, 6 months before her admission hirsutism worsened and amenorrhea, hyperpigmentation, and weakness developed. ACTH levels were 278 < pmol/L and 17OHP 91.3 nmol/L. She was admitted for parenteral antibiotics and high-dose hydrocortisone treatment. CT revealed bilateral juxta-ovarian masses (6.2 x 3.6 x 7.4 cm left and 5 x 2.2 x 3.2 cm right) that on MRI were iso-intense in T1 and hypointense in T2, with early enhancement and rapid washout. One week of high-dose hydrocortisone resulted in significant clinical and laboratory improvement and the patient was discharged with 2 mg dexamethasone/day. One month later US revealed shrinkage of the masses and dexamethasone dose was decreased. At three months from discharge, she has resumed regular menses, and a repeated MRI revealed the para-ovarian masses have shrunk. One year after the diagnosis, the para-ovarian masses have shrunk more to 2.8 x 1.9 x 4.3 on the left and 2.1 x 0.9 x 1.2 on the right with less contrast enhancement in comparison to previous test possibly due to fibrotic changes of the tissue. OARTs are rare tumors with a poorly known natural history, and surgery has been the first option in the few reported cases. We demonstrate that medical treatment is a good alternative, leading to significant tumor shrinkage over a short period. Sociedade Brasileira de Endocrinologia e Metabologia 2021-11-11 /pmc/articles/PMC10065401/ /pubmed/34762785 http://dx.doi.org/10.20945/2359-3997000000415 Text en https://creativecommons.org/licenses/by/4.0/This is an Open Access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. |
spellingShingle | Case Report Koren, Ronit Koren, Shlomit Khashper, Alla Benbassat, Carlos Pekar-Zlotin, Marina Vaknin, Zvi Ovarian adrenal rest tumor in congenital adrenal hyperplasia: Is medical treatment the first line option? |
title | Ovarian adrenal rest tumor in congenital adrenal hyperplasia: Is medical treatment the first line option? |
title_full | Ovarian adrenal rest tumor in congenital adrenal hyperplasia: Is medical treatment the first line option? |
title_fullStr | Ovarian adrenal rest tumor in congenital adrenal hyperplasia: Is medical treatment the first line option? |
title_full_unstemmed | Ovarian adrenal rest tumor in congenital adrenal hyperplasia: Is medical treatment the first line option? |
title_short | Ovarian adrenal rest tumor in congenital adrenal hyperplasia: Is medical treatment the first line option? |
title_sort | ovarian adrenal rest tumor in congenital adrenal hyperplasia: is medical treatment the first line option? |
topic | Case Report |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10065401/ https://www.ncbi.nlm.nih.gov/pubmed/34762785 http://dx.doi.org/10.20945/2359-3997000000415 |
work_keys_str_mv | AT korenronit ovarianadrenalresttumorincongenitaladrenalhyperplasiaismedicaltreatmentthefirstlineoption AT korenshlomit ovarianadrenalresttumorincongenitaladrenalhyperplasiaismedicaltreatmentthefirstlineoption AT khashperalla ovarianadrenalresttumorincongenitaladrenalhyperplasiaismedicaltreatmentthefirstlineoption AT benbassatcarlos ovarianadrenalresttumorincongenitaladrenalhyperplasiaismedicaltreatmentthefirstlineoption AT pekarzlotinmarina ovarianadrenalresttumorincongenitaladrenalhyperplasiaismedicaltreatmentthefirstlineoption AT vakninzvi ovarianadrenalresttumorincongenitaladrenalhyperplasiaismedicaltreatmentthefirstlineoption |